ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Center For Breakthrough Medicines Holdings, LLC

Official 2024 U.S. DOL Form 5500 summary for Center For Breakthrough Medicines Holdings, LLC (Center For Breakthrough Medicines 401(k) Plan · EIN 83-3099487 · PN 001): $11.91M net assets, 301 active participants, and $68.08 per $10,000 (68.08 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCenter For Breakthrough Medicines Holdings, LLC
Filing IdentifierCenter For Breakthrough Medicines 401(k) Plan · EIN 83-3099487 · PN 001
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$11.91M
Active Participants301
Direct Admin Fee Rate$68.08 per $10,000 (68.08 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderMain Line Retirement Advisors, Ll
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($145,528, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI